4.5 Article

LncRNA GAS8-AS1 downregulates lncRNA NEAT1 to inhibit glioblastoma cell proliferation

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Orthopedics

lncRNA GAS8-AS1 downregulates lncRNA UCA1 to inhibit osteosarcoma cell migration and invasion

Zhuqing Zha et al.

JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2020)

Article Medicine, Research & Experimental

lncRNA RMST Suppressed GBM Cell Mitophagy through Enhancing FUS SUMOylation

Changhong Liu et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

Article Environmental Sciences

LncRNA LINC00152 promoted glioblastoma progression through targeting the miR-107 expression

Xinzhi Liu et al.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2018)

Article Endocrinology & Metabolism

Plasma lncRNA GAS8-AS1 as a Potential Biomarker of Papillary Thyroid Carcinoma in Chinese Patients

Dongxue Zhang et al.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2017)

Review Pediatrics

Epidemiology, diagnosis, and optimal management of glioma in adolescents and young adults

Tejan P. Diwanji et al.

ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS (2017)

Review Oncology

Long Noncoding RNAs in Cancer Pathways

Adam M. Schmitt et al.

CANCER CELL (2016)

Review Medicine, General & Internal

Evolving Molecular Genetics of Glioblastoma

Qiu-Ju Li et al.

CHINESE MEDICAL JOURNAL (2016)

Article Biochemistry & Molecular Biology

Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations

Wenting Pan et al.

HUMAN MOLECULAR GENETICS (2016)

Review Pharmacology & Pharmacy

Glioblastoma multiforme: Pathogenesis and treatment

Constantinos Alifieris et al.

PHARMACOLOGY & THERAPEUTICS (2015)

Review Immunology

Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic Strategies

Sameer Agnihotri et al.

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2013)